Gene · 5394
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoantibody Profiles and Clinical Correlations in Systemic Sclerosis: A Cross-Sectional Study. | EJIFCC | 2026 | 42699467 | PubTator, text mining | PubMed |
| DNTTIP2 coordinates RNA exosome activities to ensure fidelity of human ribosome assembly. | Nat Commun | 2026 | 42693119 | PubTator, text mining | PubMed |
| Polymyositis with scleroderma-like features and an anti-PM-Scl75 antibody detected by line blot but not by protein array or immunoprecipitation: A case report and literature review. | Mod Rheumatol Case Rep | 2026 | 42644748 | PubTator, text mining | PubMed |
| RNA decay rate as a control point for long non-coding RNA function: a BRIC-based causal analysis of NEAT1. | Gene | 2026 | 42628853 | PubTator, text mining | PubMed |
| Case Report: Eosinophilic fasciitis with PM-Scl antibody positivity: expanding the serological spectrum. | Front Med (Lausanne) | 2026 | 42577884 | PubTator, text mining | PubMed |
| Inaugural complete heart block in anti-SSA negative systemic lupus erythematosus: the diagnostic role of anti-PM-Scl 100 antibodies. | Lupus | 2026 | 42522210 | PubTator, text mining | PubMed |
| ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival. | ESMO Rare Cancers | 2026 | 41994103 | PubTator, text mining | PubMed |
| Clinical relevance of specific and non-specific autoantibodies in systemic sclerosis without overlap features. | Semin Arthritis Rheum | 2026 | 41990462 | PubTator, text mining | PubMed |
| Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence Patterns. | Antibodies (Basel) | 2026 | 41874028 | PubTator, text mining | PubMed |
| The Myositis Overlap Conundrum: Differentiating Polymyositis from Inclusion Body Myositis. | Juntendo Med J | 2026 | 41859227 | PubTator, text mining | PubMed |
| Enzymes of physiological amyloidogenesis control pathological amyloid toxicity. | Life Sci Alliance | 2026 | 41850724 | PubTator, text mining | PubMed |
Anti-PM/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity. | Cureus | 2026 | 41809306 | PubTator, text mining | PubMed |
| La protein binding to telomerase RNA supports an evolutionary relationship between plant and ciliate telomerase pathways. | Nucleic Acids Res | 2026 | 41805124 | PubTator, text mining | PubMed |
| Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. | J Transl Autoimmun | 2026 | 41782636 | PubTator, text mining | PubMed |
| ANCA-Negative Granulomatosis With Polyangiitis Mimicking Sinusitis and Rhinoscleroma: A Case Report. | Case Rep Med | 2026 | 41768971 | PubTator, text mining | PubMed |
Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis. | ACR Open Rheumatol | 2026 | 41757646 | PubTator, text mining | PubMed |
| Genetic and genomic approaches to explore roles for the conserved 3'-5' exoribonuclease EXOSC10 in normal and malignant cells. | RNA | 2026 | 41741230 | PubTator, text mining | PubMed |
| Prevalence and clinical associations of anti-rods and rings antibodies in ANA-tested patients. | Immunol Res | 2026 | 41712038 | PubTator, text mining | PubMed |
| R-loop processing via REXO4-RNaseH1-mediated endo- and exo-cleavage coupling mode prevents genome instability and antitumor immunity. | Sci Adv | 2026 | 41706852 | PubTator, text mining | PubMed |
| EXOSC3 G191 Variants Trigger System-Wide Recalibration of RNA Processing Machinery. | bioRxiv | 2026 | 41659589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5394/papers